Taysha Gene Therapies, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TSHA for the last quarter is 3.41 M USD, and it's 5.36% lower compared to the previous quarter. The net income of Q1 24 is -24.06 M USD.